Healthcare -
Biotechnology - NASDAQ - US
$ 21.93
1.2 %
$ 3.16 B
Market Cap
-7.95
P/E
Price Target
Average
59.60%
Revenue Forecast
Estimate
26.91%
EBIT
Estimate
--33.02%
Net Income
Estimate
32.16%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Denali Therapeutics Inc.
Wall Street analysts predict an average 1-year price target for DNLI of $35 , with forecasts ranging from
a
low of
$22 to a high of $46 .
DNLI Lowest Price Target
Wall Street Target
22 USD
0.32%
DNLI Average Price Target
Wall Street Target
35 USD
59.60%
DNLI Highest Price Target
Wall Street Target
46 USD
109.76%
REVENUE FORECAST
Revenue Forecast Chart DNLI
EBIT FORECAST
EBIT Forecast Chart DNLI
NET INCOME FORECAST
Net Income Chart DNLI